Coya Therapeutics, Inc. Stockholders' Equity Note, Subscriptions Receivable
Coya Therapeutics, Inc. (COYA) had Stockholders' Equity Note, Subscriptions Receivable of $0 as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquityNoteSubscriptionsReceivable · last filed 2025-03-18
- 2024-09-30: Stockholders' Equity Note, Subscriptions Receivable $0.00.
- 2024-06-30: Stockholders' Equity Note, Subscriptions Receivable $0.00.
- 2024-03-31: Stockholders' Equity Note, Subscriptions Receivable $149.25K.
- 2023-12-31: Stockholders' Equity Note, Subscriptions Receivable $11.25K.
| Period end | Stockholders' Equity Note, Subscriptions Receivable |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 |
| 2024-03-31 | $149.25K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $11.25K 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |